Email this article 
The Impact of Cannabis Abuse on Psychotic Symptoms and Their Severity among Cannabis Associated Psychosis Subjects: An Indian Experience
Ramchandra Lamba(1), Sona Budaniya(2), Rajendera Kumar Acharya(3), Ram Kumar Solanki(4), Ashok Kumar(5*),
(1) S K Government Medical College, Sikar
(2) Dr S N Medical College, Jodhpur
(3) Dr S N Medical College, Jodhpur
(4) Sawai man Singh Medical College, jaipur
(5) Dr S N Medical Colege, Jodhpur
(*) Corresponding Author
Abstract
Use of cannabis for recreational, religious and cultures has been prevalent since ancient times. It is one of the commonest used illicit substance. While not all cannabis users develop psychiatric problems, heavy cannabis use may increase the risk of cognitive abnormalities, psychotic illness and mood disorders. This research aimed to evaluate severity of various psychotic symptoms in relation to variables of cannabis abuse. A cross sectional study of 30 male patients admitted at tertiary care psychiatric center with diagnosis of cannabis-associated psychosis was carried out. Cannabis abuse variables along with psychotic symptoms severity on BPRS scale were obtained. Correlation between variables of cannabis abuse and psychotic symptoms and total BPRS score were derived using Pearson correlation 2- tailed test. Hostility (83%) and excitement (77%) were most prevalent symptoms with increased severity followed by elevated mood, grandiosity, suspiciousness and motor hyperactivity. Patients with long duration and early onset of cannabis abuse presented with more severe form of psychosis. Frequency of cannabis use was not significantly correlated with total BPRS score, although amount spent over cannabis was significantly associated with total BPRS score. Family history of cannabis abuse predicted early onset of cannabis abuse.
Keywords
Full Text:
PDF (English)References
Andréasson, S., Engström, A., Allebeck, P., & Rydberg, U. (1987). Cannabis and schizophrenia a longitudinal study of Swedish conscripts. The Lancet, 330(8574), 1483-1486.
Arendt, M., Mortensen, P. B., Rosenberg, R., Pedersen, C. B., & Waltoft, B. L. (2008). Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia. Archives of general psychiatry, 65(11), 1269-1274.
Basu, D., Malhotra, A., Bhagat, A., & Varma, V. K. (1999). Cannabis psychosis and acute schizophrenia. European addiction research, 5(2), 71-73.
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Braley, G., ... .& Krystal, J. H. (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology, 29(8), 1558-1572.
Degenhardt, L., & Hall, W. (2012). Extent of illicit drug use and dependence, and their contribution to the global burden of disease. The Lancet, 379(9810), 55-70.
Feingold, D., Weiser, M., Rehm, J., & Lev-Ran, S. (2015). The association between cannabis use and mood disorders: A longitudinal study. Journal of affective disorders, 172, 211-218.
Galvez-Buccollini, J. A., Proal, A. C., Tomaselli, V., Trachtenberg, M., Coconcea, C., Chun, J., ... & Delisi, L. E. (2012). Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis. Schizophrenia research, 139(1-3), 157-160.
Hall, W., Degenhardt, L., & Sindicich, N. (2008). Illicit drug use and the burden of disease.
Hall, W., & Degenhardt, L. (2009). Adverse health effects of non-medical cannabis use. The Lancet, 374(9698), 1383-1391.
Klempova, D., Sánchez, A., Vicente, J., Barrio, G., Domingo, A., Suelves, J. M., & Ramirez, V. (2009). Consumo problemático de cannabis en estudiantes españoles de 14-18 años: Validación de escalas.
Kuddus, M., Ginawi, I. A., & Al-Hazimi, A. (2013). Cannabis sativa: An ancient wild edible plant of India. Emirates Journal of Food and Agriculture, 736-745.
Kulhalli, V., Isaac, M., & Murthy, P. (2007). Cannabis-related psychosis: Presentation and effect of abstinence. Indian journal of psychiatry, 49(4), 256.
Leweke, F. M., Gerth, C. W., & Klosterkötter, J. (2004). Cannabis-associated psychosis. CNS drugs, 18(13), 895-910.
Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016). Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophrenia bulletin, 42(5), 1262-1269.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. The Lancet, 370(9584), 319-328.
Pierre, J. M., Gandal, M., & Son, M. (2016). Cannabis-induced psychosis associated with high potency “wax dabs”. Schizophrenia Research, 172(1-3), 211-212.
Rey, J. M., Martin, A., & Krabman, P. (2004). Is the party over? Cannabis and juvenile psychiatric disorder: the past 10 years. Journal of the American Academy of Child & Adolescent Psychiatry, 43(10), 1194-1205.
Rottanburg, D., Ben-Arie, O., Robins, A., Teggin, A., & Elk, R. (1982). Cannabis-associated psychosis with hypomanic features. The Lancet, 320(8312), 1364-1366.
Rubino, T., Zamberletti, E., & Parolaro, D. (2012). Adolescent exposure to cannabis as a risk factor for psychiatric disorders. Journal of psychopharmacology, 26(1), 177-188.
Kumar, M. S., Virk, H. K., Chaudhuri, A., Mittal, A., & Lewis, G. (2008). A rapid situation and response assessment of the female regular sex partners of male drug users in South Asia: factors associated with condom use during the last sexual intercourse. International Journal of Drug Policy, 19(2), 148-158.
Swift, W., Coffey, C., Carlin, J. B., Degenhardt, L., & Patton, G. C. (2008). Adolescent cannabis users at 24 years: trajectories to regular weekly use and dependence in young adulthood. Addiction, 103(8), 1361-1370.
Thacore, V. R. (1973). Bhang psychosis. The British Journal of Psychiatry, 123(573), 225-229.
Thacore, V. R., & Shukla, S. R. P. (1976). Cannabis psychosis and paranoid schizophrenia. Archives of General Psychiatry, 33(3), 383-386.
Tunving, K. (1985). Psychiatric effects of cannabis use. Acta Psychiatrica Scandinavica, 72(3), 209-217.
United Nations Office on Drugs and Crime, 2012. (World Drug Report 2012). United Nations, New York.
von Sydow, K., Lieb, R., Pfister, H., Höfler, M., & Wittchen, H. U. (2002). What predicts incident use of cannabis and progression to abuse and dependence?: A 4-year prospective examination of risk factors in a community sample of adolescents and young adults. Drug and alcohol dependence, 68(1), 49-64.
Wittonc, J., & Reed, K. D. (2010). Cannabis and Mental Health. International Journal of Clinical Reviews.
World Health Organization. (1997). Cannabis: a health perspective and research agenda (No. WHO/MSA/PSA/97.4). World Health Organization.
Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002). Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Bmj, 325(7374), 1199.
DOI: https://doi.org/10.26539/pcr.31577
Article Metrics
Abstract Views : 699
| 
PDF Views : 534
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Ramchandra Lamba, Sona Budaniya, Rajendera Kumar Acharya, Ram Kumar Solanki, ASHOK KUMAR
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
| Publisher: Universitas Indraprasta PGRI Address: Unit Pelayanan Bimbingan dan Konseling (UPBK) | Jl. Nangka No. 58 C (TB. Simatupang), Kel. Tanjung Barat, Kec. Jagakarsa, Jakarta Selatan 12530, Jakarta, Indonesia. | |
 Psychocentrum Review is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. View My Stats |